Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.
Related Posts
Benitec Biopharma’s SWOT analysis: gene therapy stock shows clinical promise
Benitec Biopharma’s SWOT analysis: gene therapy stock shows clinical promise
Geopolitical U-Turn Drives Market Repricing Across Oil, Gold and Stocks
Geopolitical U-Turn Drives Market Repricing Across Oil, Gold and Stocks
GenAI may replace up to 12% of India’s non-farm jobs, says Goldman Sachs
Generative AI could substitute twelve percent of Indian non-agricultural jobs. Forty-eight percent of jobs will likely be complemented by this technology. Healthcare and education sectors are expected to benefit most from AI augmentation. India’s GenAI adoption depends on infrastructure and compute affordability. Widespread adoption could boost annual labor productivity growth significantly.